dr. sharpless needed further validation. e wanted to see if watson could find the same genetic mutations that his team identified when they make treatment recommendations for cancer patients. >> sharpless: we did an analysis of 1,000 patients where the humans meeting in the molecular tumor board, doing the best that they could do, had made recommendations. so, not at all a hypothetical exercise. these are real-world patients where we really conveyed information that could gar... guide care. in 99% of those cases, watson found the same thing the humans recommended. that was encouraging. >> rose: did it encourage your confidence in watson? >> sharpless: yeah, it was... it was nice to see that, well, it was also... it encouraged my confidence in the humans, you know. ( laughter ) yeah, you know. >> sharpless: but the probably more exciting part about it is, in 30% of the patients, watson found something new. and so, that's 300-plus people where watson identified a treatment that a well-meaning, hard-working group of physicians h